Anne Postler1, Cornelia Lützner2, Toni Lange2, Jochen Schmitt2, Jörg Lützner2, Klaus-Peter Günther2. 1. UniversitätsCentrum für Orthopädie, Unfall- & Plastische Chirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. Anne.postler@ukdd.de. 2. UniversitätsCentrum für Orthopädie, Unfall- & Plastische Chirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Abstract
BACKGROUND: The decision for total hip arthroplasty (THA) is based on pain, loss of function, radiological changes and failed conservative therapy. These criteria are rarely based on systematic research and have not been integrated in generally accepted treatment guidelines. Aim of our study was, therefore, to analyse which decision criteria German orthopaedic and trauma surgeons use in order to recommend THA for patients with hip osteoarthritis. MATERIALS AND METHODS: From 10/2019 to 07/2020 we conducted a nation-wide survey among 218 orthopaedic and trauma surgeons about their criteria for and against THA surgery, as well as their treatment objectives. RESULTS: 147 fully completed questionnaires were analysed. Pain (99%), limitation of movement (99%), as well as impairment of walking distance (97%), and the subjective burden (97%) were the most frequent criteria. 97% and 96% of surgeons consider prescription of analgesics and physical therapy, as well as a lack of their effectiveness, as criteria for THA. 87% see radiological changes grade Kellgren & Lawrence III as threshold. A recommendation against surgery is triggered by obesity (BMI ≥ 40 kg/m2) in 48% and by the presence of an active infection in 96%. CONCLUSIONS: Current surgeons' practice criteria of recommendations for THA in Germany seem to reflect widely nationally and internationally discussed recommendations. Particular attention is given to patient factors like pain, loss of function and subjective burden, as well as previous conservative treatment and contraindications, like poorly controlled diabetes or an active infection, whereas morbid obesity is not seen as contraindication by all surgeons.
BACKGROUND: The decision for total hip arthroplasty (THA) is based on pain, loss of function, radiological changes and failed conservative therapy. These criteria are rarely based on systematic research and have not been integrated in generally accepted treatment guidelines. Aim of our study was, therefore, to analyse which decision criteria German orthopaedic and trauma surgeons use in order to recommend THA for patients with hip osteoarthritis. MATERIALS AND METHODS: From 10/2019 to 07/2020 we conducted a nation-wide survey among 218 orthopaedic and trauma surgeons about their criteria for and against THA surgery, as well as their treatment objectives. RESULTS: 147 fully completed questionnaires were analysed. Pain (99%), limitation of movement (99%), as well as impairment of walking distance (97%), and the subjective burden (97%) were the most frequent criteria. 97% and 96% of surgeons consider prescription of analgesics and physical therapy, as well as a lack of their effectiveness, as criteria for THA. 87% see radiological changes grade Kellgren & Lawrence III as threshold. A recommendation against surgery is triggered by obesity (BMI ≥ 40 kg/m2) in 48% and by the presence of an active infection in 96%. CONCLUSIONS: Current surgeons' practice criteria of recommendations for THA in Germany seem to reflect widely nationally and internationally discussed recommendations. Particular attention is given to patient factors like pain, loss of function and subjective burden, as well as previous conservative treatment and contraindications, like poorly controlled diabetes or an active infection, whereas morbid obesity is not seen as contraindication by all surgeons.
Entities:
Keywords:
Contraindications; Osteoarthritis of the hip; Pain; Survey; Total hip replacement
Authors: K E Dreinhöfer; P Dieppe; T Stürmer; D Gröber-Grätz; M Flören; K-P Günther; W Puhl; H Brenner Journal: Ann Rheum Dis Date: 2006-01-26 Impact factor: 19.103
Authors: L Gossec; S Paternotte; J F Maillefert; C Combescure; P G Conaghan; A M Davis; K-P Gunther; G Hawker; M Hochberg; J N Katz; M Kloppenburg; K Lim; L S Lohmander; N N Mahomed; L March; K Pavelka; L Punzi; E M Roos; L Sanchez-Riera; J A Singh; M E Suarez-Almazor; M Dougados Journal: Osteoarthritis Cartilage Date: 2010-10-31 Impact factor: 6.576
Authors: Laure Gossec; Simon Paternotte; Clifton O Bingham; Daniel O Clegg; Philippe Coste; Philip G Conaghan; Aileen M Davis; Giampaolo Giacovelli; Klaus-Peter Gunther; Gillian Hawker; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Margreet Kloppenburg; Arturo Lanzarotti; Keith Lim; L Stefan Lohmander; Nizar N Mahomed; Jean Francis Maillefert; Rebecca L Manno; Lyn M March; Steven A Mazzuca; Karel Pavelka; Leonardo Punzi; Ewa M Roos; Lucio C Rovati; Helen Shi; Jasvinder A Singh; Maria E Suarez-Almazor; Eleonora Tajana-Messi; Maxime Dougados Journal: J Rheumatol Date: 2011-08 Impact factor: 4.666
Authors: L Frankel; C Sanmartin; B Conner-Spady; D A Marshall; L Freeman-Collins; A Wall; G A Hawker Journal: Osteoarthritis Cartilage Date: 2012-05-31 Impact factor: 6.576
Authors: Maaike G J Gademan; Stefanie N Hofstede; Thea P M Vliet Vlieland; Rob G H H Nelissen; Perla J Marang-van de Mheen Journal: BMC Musculoskelet Disord Date: 2016-11-09 Impact factor: 2.362
Authors: Jonathan T Evans; Jonathan P Evans; Robert W Walker; Ashley W Blom; Michael R Whitehouse; Adrian Sayers Journal: Lancet Date: 2019-02-14 Impact factor: 79.321